10 Unusual Stocks Attracting Huge Interest In The Market Right Now

vladimirputin wink tbi

Here’s where we see the heat this morning:

Today we have huge results from Gazprom, bullish words from Delta, China’s trying to block BHP’s Potash buy, plus some wild pharma catalysts, and more…

HUGE DEAL: Orexigen (OREX) gets $1bn marketing deal with Takeda for their obesity drug, stock going nuts already

MACAU BABY: Markets seem to be pretty happy about Melco Crown's (MPEL) latest Macau revenue

High volume, over 41,000 shares as of 8:09 AM. Read about the Macau data here.

ADR WATCH: Natural gas giant Gazprom's profit triples (ADRs are OGZPY)

Read about it here. See the stock performance in Russia here.

M&A: On second thought, being bought out isn't as easy as it looks for Burger King (BKC)... shares losing some speculative steam

EARNINGS: Canada's leading Toronto Dominion Bank (TD) misses estimates by a sliver, but profit up 29%

SAME STORE SALES: Costco (COST) blows away analyst estimates

Same store sales rise 7% in August vs. 4.2% expected. Read about it here.

BULLISH OUTLOOK: Delta (DAL) says August traffic very strong

M&A: China reportedly trying to block BHP's potential takeover of fertiliser giant Potash (POT)

PHARMA CATALYST: Drug maker Cardiome (CRME) nails $30 million milestone payment

MICRO CAP BAGS A DEAL: Amtech (ASYS) gets $37 million of solar orders, not bad when your market cap is just $128 million

ODD: Spine device maker Alphatec (ATEC) running up pre-market and has a wild chart

Might be worth a look. Forbes called it THE biggest biotech loser here.

PHARMA CATALYST: Cerus (CERS) reports positive outcome from blood treatment study with the Red Cross

Business Insider Emails & Alerts

Site highlights each day to your inbox.

Follow Business Insider Australia on Facebook, Twitter, LinkedIn, and Instagram.